Senior Registrar in Neurology, National Hospital, No. 15B1, Campbell Place, Dehiwela, Sri Lanka Colombo, Sri Lanka.
BMC Neurol. 2022 Oct 19;22(1):387. doi: 10.1186/s12883-022-02917-6.
Neuro-melioidosis, comprising 4% of all cases of melioidosis carries a risk of high morbidity and mortality. We describe two Sri Lankan patients presenting with long segment myelitis secondary to melioidosis.
Case 1: 47-year-old male presented with right side hemiparesis which progressed rapidly to quadriparesis. Initial cerebro spinal fluid (CSF) analysis revealed protein 76 mg/dl and glucose 72 mg/dl but without a cellular reaction. MRI spine revealed long segment myelitis with contrast enhancement. The patient was treated with intravenous methyl prednisolone pulses (IV MPP) and plasma exchanges(PLEX) on suspicion of an immune mediated myelitis but without success. A repeat MRI revealed high signal changes in the brain stem and along the entire spinal cord with contrast enhancement. MRI brain after treatment with MPP/PLEX showed enhancing hyper intensities along the corticospinal tracts. The repeat CSF revealed protein 1187 mg/dl, glucose 78 mg/dl, lymphocytes 1600/mm3 and neutrophils 10,200/mm3. CSF culture has become positive for Burkholderia pseudomallei. Serum melioidosis antibody titre was 1: 320. He was started on IV meropenem with oral cotrimoxazole for 12 weeks followed by oral co trimoxazole. But he had poor clinical recovery. Case 2: 47-year-old female presented with bilateral lower limb weakness for 1-week duration. On examination, she had flaccid paraparesis with a sensory level at T11. Inflammatory markers were elevated. CSF analysis revealed protein 50 mg/dl with lymphocytes 172/mm3. MRI pan spine revealed a long segment myelitis. Serum melioidosis antibody titre was 1: 640. She was treated with IV meropenem for 8 weeks followed by oral co-trimoxazole with an excellent clinical and radiological response.
Numerous neurological manifestations have been described with melioidosis, however long segment myelitis with a positive CSF culture is not yet reported. These cases signify the importance of considering melioidosis as a differential in patients with long segment myelitis especially in endemic areas.
神经型类鼻疽占所有类鼻疽病例的 4%,具有高发病率和死亡率的风险。我们描述了两名因类鼻疽导致长节段脊髓炎的斯里兰卡患者。
病例 1:47 岁男性,表现为右侧偏瘫,迅速进展为四肢瘫痪。最初的脑脊液(CSF)分析显示蛋白 76mg/dl,葡萄糖 72mg/dl,但无细胞反应。脊髓 MRI 显示长节段脊髓炎伴对比增强。怀疑免疫介导性脊髓炎,患者接受了静脉甲基泼尼松龙脉冲(IV MPP)和血浆置换(PLEX)治疗,但未成功。重复 MRI 显示脑干和整个脊髓的高信号改变伴对比增强。MPP/PLEX 治疗后的脑 MRI 显示沿皮质脊髓束增强的高信号。重复 CSF 显示蛋白 1187mg/dl,葡萄糖 78mg/dl,淋巴细胞 1600/mm3,中性粒细胞 10200/mm3。CSF 培养对伯克霍尔德氏菌假单胞菌呈阳性。血清类鼻疽抗体滴度为 1:320。患者开始接受静脉美罗培南联合口服复方磺胺甲噁唑治疗 12 周,然后改为口服复方磺胺甲噁唑。但他的临床康复情况不佳。病例 2:47 岁女性,双下肢无力 1 周。体检时,她表现为弛缓性截瘫,感觉平面位于 T11。炎症标志物升高。CSF 分析显示蛋白 50mg/dl,淋巴细胞 172/mm3。全脊柱 MRI 显示长节段脊髓炎。血清类鼻疽抗体滴度为 1:640。患者接受了 8 周的静脉美罗培南治疗,然后改为口服复方磺胺甲噁唑,临床和放射学反应良好。
类鼻疽有许多神经表现,但尚未有 CSF 培养阳性的长节段脊髓炎报道。这些病例表明,在流行地区,尤其在长节段脊髓炎患者中,应考虑类鼻疽作为鉴别诊断。